A detailed history of One Ascent Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, One Ascent Family Office, LLC holds 551 shares of LLY stock, worth $562,956. This represents 0.43% of its overall portfolio holdings.

Number of Shares
551
Previous 535 2.99%
Holding current value
$562,956
Previous $417,000 0.72%
% of portfolio
0.43%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$625.65 - $812.69 $10,010 - $13,003
16 Added 2.99%
551 $420,000
Q2 2025

Aug 06, 2025

SELL
$713.71 - $898.95 $271,923 - $342,499
-381 Reduced 41.59%
535 $417,000
Q1 2025

May 05, 2025

BUY
$725.72 - $929.72 $351,974 - $450,914
485 Added 112.53%
916 $752,000
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $313,423 - $401,717
431 New
431 $332,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track One Ascent Family Office, LLC Portfolio

Follow One Ascent Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Family Office, LLC with notifications on news.